| 已發行股份 | 110,427,682 shares |
| 內部人士股份 | 15,272,836 shares |
| 內部持股 | 13.83 % |
| 所有內部人士 | 53 |
內部人士情緒分數
「內部人士情緒分數」用於查找被公司內部人士購入的公司。
它是一個複雜的多因素量化模型的結果，該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例，以及內部人士擁有的總股份的指標。該分數的範圍從0到100，數值越高表示相對於同行業而言具有更高程度的內部人士持股水平，50為平均值。
更新頻率：每日
高管情緒分數
「高管情緒分數」用於查找被公司管理層購入的公司。
根據定義，公司高管是公司內部人士，但與其他內部人士（10%的股東和董事會成員）不同，公司高管每天在公司工作，而且他們使用自己的資金進行交易。（10%的股東和董事會成員通常是基金經理，管理著其他人的資金。）因此，公司高管進行的內幕交易更為重要性，應該被適當地重視和關注。
如同「內部人士情緒分數」，「高管情緒分數」也是一個複雜的多因素量化模型的計算結果，該模型能夠辨識具有最高高管累積持有水平的公司。
更新頻率：每日
關鍵內部人士指標
此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。
舉例來說，一般認為內部人士的買入是一個積極的指標，因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少（甚至有內部人士賣出）的公司。
內幕交易圖表
以下圖表顯示了Viridian Therapeutics, Inc.內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。
內部人員名單及盈利指標
這張表格顯示已知的內部人員名單，從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外，我們還提供了最新披露的持股信息。此外，我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊，請查看YouTube網絡研討會。
See our leaderboard of most profitable insider traders.
| 內部人士 | 平均收益（%） | 持股 數量 |
分拆 調整 |
|---|---|---|---|
|
Atlas Venture Fund VII L P
10% Owner -
|
6,285,160 | 419,011 | |
| Beetham Thomas W. Chief Operating Officer - [O] | 13,361 | 13,361 | |
| Bruce Booth Director - [D] | 1,351,090 | 90,073 | |
| Christopher Bowden | 24,000 | ||
|
Cohen Steven A/sac Capital Mgmt Lp
10% Owner -
|
426,162 | 426,162 | |
| Thomas Ciulla Chief Medical Officer - [O] | 762 | 762 | |
| John W Creecy Director - [D] | 5,413,126 | 360,875 | |
| Diana Escolar | 270,000 | ||
|
Fhmlsp, L.l.c.
10% Owner -
|
1,505,200 | 1,505,200 | |
|
Fhmlsp, L.p.
10% Owner -
|
1,505,200 | 1,505,200 | |
|
Fairmount Funds Management LLC
Director, 10% Owner -
[D]
|
5,090,928 | 5,090,928 | |
| Fairmount Healthcare Fund GP LLC Director - [D] | 938,233 | 1,845,813 | |
| Fairmount Healthcare Fund II GP LLC Director - [D] | 938,233 | 5,090,928 | |
| Fairmount Healthcare Fund II L.P. Director - [D] | 938,233 | 5,090,928 | |
| Fairmount Healthcare Fund L.P. Director - [D] | 938,233 | 1,845,813 | |
|
Frazier Life Sciences Public Fund, L.P.
10% Owner -
|
1,505,200 | 1,505,200 | |
| David A Gonyer Director - [D] | 1,899 | 1,899 |
| 內部人士 | 平均收益（%） | 持股 數量 |
分拆 調整 |
|---|---|---|---|
| Seth Harmon Chief Financial Officer - [O] | 7,850 | 7,850 | |
| Peter Evan Harwin | 24,000 | ||
| Hatfield Jeffrey S. | 24,000 | ||
| Hughes Thomas E. Director - [D] | 12,827 | 855 | |
| Kristian Humer | 90,000 | ||
| Robert Brian Johnson | 0 | ||
| Kevin Koch | 24,000 | ||
| Barrett Katz Chief Medical Officer - [O] | 0 | 0 | |
| Tomas Kiselak | 24,000 | ||
|
Peter Kolchinsky
10% Owner -
|
410,686 | 410,686 | |
|
Alpha, Lllp Lebow
10% Owner -
|
4,465,258 | 4,465,258 | |
|
Bennett S Lebow
Director, 10% Owner -
[D]
|
280,600 | 18,707 | |
| Kyle Lefkoff Director - [D] | 463,473 | 30,898 | |
| Leverone Jason A. CFO, Treasurer & Secretary - [O] | 48,829 | 3,255 | |
| Adam Scott Levy Chief Business Officer - [O] | 10,540 | 703 | |
|
Logos Global Master Fund LP
10% Owner -
|
550,000 | 550,000 | |
| Mahoney Stephen F. President and CEO, Director - [D] [O] | 33,349 | 33,349 | |
| William Stuart Marshall President & CEO, Director - [D] [O] | 270,646 | 18,043 |
| 內部人士 | 平均收益（%） | 持股 數量 |
分拆 調整 |
|---|---|---|---|
| Lara Meisner Chief Legal Officer - [O] | 29,971 | 29,971 | |
| Arlene Morris | 24,000 | ||
| Scott Dunseth Myers Chief Executive Officer, Director - [D] [O] | 259,500 | 259,500 | |
|
Point72 Asset Management, L.P.
10% Owner -
|
426,162 | 426,162 | |
|
Point72 Capital Advisors, Inc.
10% Owner -
|
426,162 | 426,162 | |
|
Ra Capital Management, Llc
10% Owner -
|
410,686 | 410,686 | |
|
RA Capital Healthcare Fund LP
10% Owner -
|
410,686 | 410,686 | |
| Paul D Rubin | 87,000 | ||
| Rauch Lee M. | 900,000 | ||
|
Remeditex Ventures LLC
10% Owner -
|
5,413,126 | 360,875 | |
| Samuel D Riccitelli President & CEO, Director - [D] [O] | 571,370 | 571,370 | |
| Tamara A Seymour CFO, Secretary, Treasurer - [O] | 106,447 | 106,447 | |
| Douglas A Schuling Director - [D] | 10,500 | 10,500 | |
|
Shah Rajeev M.
10% Owner -
|
410,686 | 410,686 | |
| Robin L Smith Director - [D] | 1,900 | 1,900 | |
| Joseph L Turner | 24,000 | ||
| Jennifer Tousignant Chief Legal Officer - [O] | 3,494 | 3,494 | |
| Jonathan Violin Chief Executive Officer, Director - [D] [O] | 480,905 | 480,905 |
Report errors via our new Insider Auditing Tool
追蹤內部人士買入記錄 - 短期收益分析
在這一部分，我們分析了在 VRDN / Viridian Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況， 結果僅為理論值。 .
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。 經調整股數 已按拆股調整。
追蹤內部人士賣出記錄 - 短期虧損分析
在這一部分，我們分析了在 VRDN / Viridian Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況， 結果僅為理論值。 .
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。 經調整股數 已按拆股調整。
交易歷史
點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易，將在標記為 10b-5 的欄位中顯示 X。
| 呈報 日期 |
交易 日期 |
表格 | 內部人士 | 證券代碼 | 證券種類 | 代碼 | 直接 | 行使 價格 |
單位 價格 |
股數 變化 |
價值 變化 (1K) |
剩餘 期權 |
剩餘 股份 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | 2026-05-11 | 4 | Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P. | VRDN | Common Stock | I | 17.0000 | 1,176,470 | 20,000 | 5,090,928 | ||||
| 2026-03-09 | 2026-03-03 | 4/A | Harmon Seth | VRDN | Common Stock | D | 30.1900 | -2,031 | -61 | 7,850 | ||||
| 2026-03-09 | 2026-03-03 | 4/A | Beetham Thomas W. | VRDN | Common Stock | D | 30.1900 | -3,048 | -92 | 13,361 | ||||
| 2026-03-09 | 2026-03-03 | 4/A | Mahoney Stephen F. | VRDN | Common Stock | D | 30.1900 | -7,408 | -224 | 33,349 | ||||
| 2026-03-09 | 2026-03-03 | 4/A | Tousignant Jennifer | VRDN | Common Stock | D | 30.1900 | -1,675 | -51 | 3,494 | ||||
| 2026-03-04 | 2026-03-03 | 4 | Tousignant Jennifer | VRDN | Common Stock | D | 29.3200 | -1,724 | -51 | 3,445 | ||||
| 2026-03-04 | 2026-03-03 | 4 | Tousignant Jennifer | VRDN | Common Stock | D | 5,169 | 5,169 | ||||||
| 2026-03-04 | 2026-03-03 | 4 | Harmon Seth | VRDN | Common Stock | D | 29.3200 | -2,091 | -61 | 7,790 | ||||
| 2026-03-04 | 2026-03-03 | 4 | Harmon Seth | VRDN | Common Stock | D | 6,267 | 9,881 | ||||||
| 2026-03-04 | 2026-03-03 | 4 | Beetham Thomas W. | VRDN | Common Stock | D | 29.3200 | -3,138 | -92 | 13,271 | ||||
| 2026-03-04 | 2026-03-03 | 4 | Beetham Thomas W. | VRDN | Common Stock | D | 9,409 | 16,409 | ||||||
| 2026-03-04 | 2026-03-03 | 4 | Mahoney Stephen F. | VRDN | Common Stock | D | 29.3200 | -7,627 | -224 | 33,130 | ||||
| 2026-03-04 | 2026-03-03 | 4 | Mahoney Stephen F. | VRDN | Common Stock | D | 18,357 | 40,757 | ||||||
| 2026-01-02 | 2025-12-31 | 4 | Tousignant Jennifer | VRDN | Common Stock | D | 31.1600 | -2,272 | -71 | 0 | ||||
| 2025-10-27 | 2025-10-23 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 22.0000 | 454,545 | 10,000 | 3,914,458 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 12.3100 | 12,500 | 154 | 3,459,913 | ||||
| 2025-06-11 | 2025-06-09 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 7.8000 | 1,600 | 12 | 3,447,413 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Beetham Thomas W. | VRDN | Common Stock | D | 23.4100 | 5,000 | 117 | 6,000 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Mahoney Stephen F. | VRDN | Common Stock | D | 23.3300 | 21,400 | 499 | 21,400 | ||||
| 2024-09-17 | 2024-09-13 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 18.7500 | 1,600,000 | 30,000 | 3,445,813 | ||||
| 2024-04-01 | 2024-03-28 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 5,859 | 1,845,813 | ||||||
| 2024-04-01 | 2024-03-28 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | VRDN | Common Stock | I | -5,859 | 0 | ||||||
| 2024-01-24 | 2024-01-22 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 21.0000 | 476,190 | 10,000 | 1,839,954 | ||||
| 2024-01-12 | 3 | Ciulla Thomas | VRDN | Common Stock | D | 762 | ||||||||
| 2023-06-20 | 2023-06-16 | 4 | Meisner Lara | VRDN | Common Stock | D | 28.3500 | -27 | -1 | 29,971 | ||||
| 2023-06-20 | 2023-06-16 | 4 | Meisner Lara | VRDN | Common Stock | D | 23.0300 | 27 | 1 | 29,998 | ||||
| 2023-06-20 | 2023-06-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 28.0200 | -2,269 | -64 | 29,971 | ||||
| 2023-06-20 | 2023-06-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 23.0300 | 2,269 | 52 | 32,240 | ||||
| 2023-06-06 | 2023-06-06 | 4 | Meisner Lara | VRDN | Common Stock | D | 25.0200 | -5,126 | -128 | 29,971 | ||||
| 2023-06-06 | 2023-06-06 | 4 | Meisner Lara | VRDN | Common Stock | D | 18.5100 | 5,126 | 95 | 35,097 | ||||
| 2023-06-06 | 2023-06-05 | 4 | Meisner Lara | VRDN | Common Stock | D | 25.0300 | -499 | -12 | 29,971 | ||||
| 2023-06-06 | 2023-06-05 | 4 | Meisner Lara | VRDN | Common Stock | D | 18.5100 | 499 | 9 | 30,470 | ||||
| 2023-06-06 | 2023-06-02 | 4 | Meisner Lara | VRDN | Common Stock | D | 24.2100 | -1,875 | -45 | 29,971 | ||||
| 2023-06-06 | 2023-06-02 | 4 | Meisner Lara | VRDN | Common Stock | D | 14.0000 | 1,875 | 26 | 31,846 | ||||
| 2023-04-12 | 2023-04-12 | 4 | Myers Scott Dunseth | VRDN | Common Stock | D | 25.3697 | 4,000 | 101 | 259,500 | ||||
| 2023-03-13 | 2023-03-13 | 4 | Myers Scott Dunseth | VRDN | Common Stock | D | 29.1499 | 5,500 | 160 | 255,500 | ||||
| 2023-03-10 | 2023-03-09 | 4 | Meisner Lara | VRDN | Common Stock | D | 29.0700 | -29,971 | -871 | 0 | ||||
| 2023-02-07 | 2023-02-06 | 4 | Myers Scott Dunseth | VRDN | Common Stock | D | 250,000 | 250,000 | ||||||
| 2023-02-07 | 2023-02-02 | 4/A | Violin Jonathan | VRDN | Common Stock | D | 36.8000 | -50,000 | -1,840 | 480,905 | ||||
| 2023-02-07 | 2023-02-02 | 4/A | Violin Jonathan | VRDN | Common Stock | D | 0.1500 | 50,000 | 8 | 530,905 | ||||
| 2023-02-03 | 2023-02-02 | 4 | Violin Jonathan | VRDN | Common Stock | D | 36.8000 | -50,000 | -1,840 | 430,905 | ||||
| 2023-01-25 | 2023-01-23 | 4 | Meisner Lara | VRDN | Common Stock | D | 35.6600 | -6,843 | -244 | 0 | ||||
| 2023-01-25 | 2023-01-23 | 4 | Meisner Lara | VRDN | Common Stock | D | 14.0000 | 1,872 | 26 | 6,843 | ||||
| 2023-01-25 | 2023-01-23 | 4 | Meisner Lara | VRDN | Common Stock | D | 23.0300 | 4,971 | 114 | 4,971 | ||||
| 2023-01-18 | 2023-01-17 | 4 | Katz Barrett | VRDN | Common Stock | D | 37.2100 | -24,853 | -925 | 0 | ||||
| 2023-01-18 | 2023-01-17 | 4 | Katz Barrett | VRDN | Common Stock | D | 23.0300 | 24,853 | 572 | 24,853 | ||||
| 2023-01-18 | 2023-01-13 | 4 | Katz Barrett | VRDN | Common Stock | D | 37.0100 | -4,147 | -153 | 0 | ||||
| 2023-01-18 | 2023-01-13 | 4 | Katz Barrett | VRDN | Common Stock | D | 23.0300 | 4,147 | 96 | 4,147 | ||||
| 2023-01-11 | 2023-01-10 | 4 | Katz Barrett | VRDN | Common Stock | D | 35.3000 | -47,377 | -1,672 | 0 | ||||
| 2023-01-11 | 2023-01-10 | 4 | Katz Barrett | VRDN | Common Stock | D | 23.0300 | 47,377 | 1,091 | 47,377 | ||||
| 2023-01-11 | 2023-01-09 | 4 | Katz Barrett | VRDN | Common Stock | D | 33.0400 | -12,623 | -417 | 0 | ||||
| 2023-01-11 | 2023-01-09 | 4 | Katz Barrett | VRDN | Common Stock | D | 23.0300 | 12,623 | 291 | 12,623 | ||||
| 2022-12-22 | 2022-12-21 | 4 | Meisner Lara | VRDN | Common Stock | D | 29.1900 | -16,326 | -477 | 0 | ||||
| 2022-12-22 | 2022-12-21 | 4 | Meisner Lara | VRDN | Common Stock | D | 23.0300 | 16,326 | 376 | 16,326 | ||||
| 2022-12-22 | 2022-12-20 | 4 | Meisner Lara | VRDN | Common Stock | D | 28.0700 | -600 | -17 | 0 | ||||
| 2022-12-22 | 2022-12-20 | 4 | Meisner Lara | VRDN | Common Stock | D | 23.0300 | 600 | 14 | 600 | ||||
| 2022-12-19 | 2022-12-16 | 4 | Meisner Lara | VRDN | Common Stock | D | 28.4400 | -1,297 | -37 | 0 | ||||
| 2022-12-19 | 2022-12-16 | 4 | Meisner Lara | VRDN | Common Stock | D | 23.0300 | 1,297 | 30 | 1,297 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 28.0800 | -300 | -8 | 0 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 23.0300 | 300 | 7 | 300 | ||||
| 2022-12-14 | 2022-12-14 | 4 | Meisner Lara | VRDN | Common Stock | D | 28.1200 | -15,656 | -440 | 0 | ||||
| 2022-12-14 | 2022-12-14 | 4 | Meisner Lara | VRDN | Common Stock | D | 23.0300 | 15,656 | 361 | 15,656 | ||||
| 2022-12-14 | 2022-12-12 | 4 | Meisner Lara | VRDN | Common Stock | D | 28.0500 | -600 | -17 | 0 | ||||
| 2022-12-14 | 2022-12-12 | 4 | Meisner Lara | VRDN | Common Stock | D | 23.0300 | 600 | 14 | 600 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 22.0500 | -8,125 | -179 | 0 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 14.0000 | 8,125 | 114 | 8,125 | ||||
| 2022-08-19 | 2022-08-17 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 23.5000 | 425,531 | 10,000 | 1,363,764 | ||||
| 2022-06-02 | 2022-06-01 | 4 | Violin Jonathan | VRDN | Common Stock | D | 12.2000 | -30,000 | -366 | 480,905 | ||||
| 2022-05-04 | 2022-05-02 | 4 | Violin Jonathan | VRDN | Common Stock | D | 13.0400 | -30,000 | -391 | 510,905 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Violin Jonathan | VRDN | Common Stock | D | 18.9300 | -3,600 | -68 | 540,905 | ||||
| 2022-04-05 | 2022-04-01 | 4 | Violin Jonathan | VRDN | Common Stock | D | 18.9200 | -26,400 | -499 | 544,505 | ||||
| 2022-03-03 | 2022-03-02 | 4 | Violin Jonathan | VRDN | Common Stock | D | 17.3600 | -11,106 | -193 | 570,905 | ||||
| 2022-03-03 | 2022-03-01 | 4 | Violin Jonathan | VRDN | Common Stock | D | 17.8200 | -18,894 | -337 | 582,011 | ||||
| 2022-02-03 | 2022-02-02 | 4 | Humer Kristian | VRDN | Stock Option (Right to Buy) | D | 18.51 | 90,000 | 90,000 | |||||
| 2022-02-03 | 2022-02-02 | 4 | Katz Barrett | VRDN | Stock Option (Right to Buy) | D | 18.51 | 110,000 | 110,000 | |||||
| 2022-02-03 | 2022-02-02 | 4 | Meisner Lara | VRDN | Stock Option (Right to Buy) | D | 18.51 | 90,000 | 90,000 | |||||
| 2022-02-03 | 2022-02-03 | 4 | Violin Jonathan | VRDN | Common Stock | D | 19.1600 | -909 | -17 | 600,905 | ||||
| 2022-02-03 | 2022-02-02 | 4 | Violin Jonathan | VRDN | Stock Option (Right to Buy) | D | 18.51 | 280,000 | 280,000 | |||||
| 2022-02-03 | 2022-02-02 | 4 | Violin Jonathan | VRDN | Common Stock | D | 18.4700 | -12,340 | -228 | 601,814 | ||||
| 2022-02-03 | 2022-02-01 | 4 | Violin Jonathan | VRDN | Common Stock | D | 19.5500 | -16,751 | -327 | 614,154 | ||||
| 2022-01-03 | 2021-12-31 | 4 | Humer Kristian | VRDN | Stock Option (Right to Buy) | D | 19.77 | 121,371 | 121,371 | |||||
| 2021-12-10 | 2021-12-08 | 4 | Violin Jonathan | VRDN | Series A Non-Voting Convertible Preferred Stock | D | -9,413 | 0 | ||||||
| 2021-12-10 | 2021-12-08 | 4 | Violin Jonathan | VRDN | Common Stock | D | 627,564 | 630,905 | ||||||
| 2021-09-28 | 2021-09-23 | 4 | Frazier Life Sciences Public Fund, L.P. | VRDN | Common Stock | D | 11.0000 | 200,000 | 2,200 | 1,505,200 | ||||
| 2021-09-23 | 2021-09-21 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 11.0000 | 909,000 | 9,999 | 938,233 | ||||
| 2021-08-26 | 3 | FHMLSP, L.P. | VRDN | Common Stock | D | 1,305,200 | ||||||||
| 2021-07-27 | 2021-07-26 | 4 | Humer Kristian | VRDN | Stock Option (Right to Buy) | D | 17.09 | 360,000 | 360,000 | |||||
| 2021-07-15 | 2021-07-14 | 4 | Moses Jennifer K. | VRDN | Stock Option (Right to Buy) | D | 17.88 | 25,000 | 25,000 | |||||
| 2021-06-16 | 2021-06-03 | 4 | Kiselak Tomas | VRDN | Stock Option (Right to Buy) | D | 16.60 | 12,500 | 12,500 | |||||
| 2021-06-16 | 2021-06-03 | 4 | Harwin Peter Evan | VRDN | Stock Option (Right to Buy) | D | 16.60 | 12,500 | 12,500 | |||||
| 2021-06-16 | 2021-06-03 | 4 | Morris Arlene | VRDN | Stock Option (Right to Buy) | D | 16.60 | 12,500 | 12,500 | |||||
| 2021-02-08 | 2021-02-04 | 4 | TURNER JOSEPH L | VRDN | Director Stock Option (Right to Buy) | D | 20.50 | 25,000 | 25,000 | |||||
| 2021-02-08 | 2021-02-04 | 4 | Harwin Peter Evan | VRDN | Director Stock Option (Right to Buy) | D | 20.50 | 25,000 | 25,000 | |||||
| 2021-02-08 | 2021-02-04 | 4 | Hatfield Jeffrey S. | VRDN | Director Stock Option (Right to Buy) | D | 20.50 | 25,000 | 25,000 | |||||
| 2021-02-08 | 2021-02-04 | 4 | Kiselak Tomas | VRDN | Director Stock Option (Right to Buy) | D | 20.50 | 25,000 | 25,000 | |||||
| 2021-02-08 | 2021-02-04 | 4 | Morris Arlene | VRDN | Director Stock Option (Right to Buy) | D | 20.50 | 25,000 | 25,000 | |||||
| 2021-01-21 | 2021-01-18 | 4 | Katz Barrett | VRDN | Employee Stock Option (right to buy) | D | 23.03 | 356,000 | 356,000 | |||||
| 2021-01-20 | 2021-01-18 | 4 | Leverone Jason A. | VRDN | Employee Stock Option (right to buy) | D | 23.03 | 311,785 | 311,785 | |||||
| 2021-01-20 | 2021-01-18 | 4 | Violin Jonathan | VRDN | Employee Stock Option (right to buy) | D | 23.03 | 800,075 | 800,075 | |||||
| 2021-01-19 | 2021-01-18 | 4 | Rauch Lee M. | MGEN | Employee Stock Option (right to buy) | D | 23.03 | 15,000 | 15,000 | |||||
| 2020-12-17 | 3 | Shah Rajeev M. | MGEN | Common Stock | I | 410,686 | ||||||||
| 2020-11-20 | 3 | COHEN STEVEN A/SAC CAPITAL MGMT LP See footnotes | MGEN | Common Stock | I | 426,162 | ||||||||
| 2020-11-16 | 2020-11-13 | 4 | Logos Global Master Fund LP | MGEN | Common Stock | D | 14.8389 | 126,667 | 1,880 | 550,000 | ||||
| 2020-11-16 | 2020-11-09 | 4 | Logos Global Master Fund LP | MGEN | Common Stock | D | 1.1641 | 100,000 | 116 | 6,350,000 | ||||
| 2020-11-16 | 2020-11-09 | 4 | Logos Global Master Fund LP | MGEN | Common Stock | D | 1.0979 | 250,000 | 274 | 6,250,000 | ||||
| 2020-11-16 | 3 | Logos Global Master Fund LP | MGEN | Common Stock | D | 6,000,000 | ||||||||
| 2020-10-30 | 2020-10-27 | 4 | Violin Jonathan | MGEN | Series A Non-Voting Convertible Preferred Stock | D | 9,413 | 9,413 | ||||||
| 2020-10-30 | 2020-10-27 | 4 | Violin Jonathan | MGEN | Employee Stock Option (Right to Buy) | D | 0.01 | 4,338,079 | 4,338,079 | |||||
| 2020-10-30 | 2020-10-27 | 4 | Violin Jonathan | MGEN | Common Stock | D | 50,124 | 50,124 | ||||||
| 2020-10-30 | 3 | Violin Jonathan | MGEN | Common Stock | D | 50,124 | ||||||||
| 2020-10-30 | 2020-10-30 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | MGEN | Series A Non-Voting Convertible Preferred Stock | I | 465.9600 | 28,843 | 13,440 | 111,192 | ||||
| 2020-10-30 | 2020-10-30 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | MGEN | Series A Non-Voting Convertible Preferred Stock | I | 465.9600 | 5,494 | 2,560 | 21,999 | ||||
| 2020-10-30 | 3 | Fairmount Healthcare Fund II L.P. By funds | MGEN | Common Stock | I | 526,393 | ||||||||
| 2020-10-29 | 2020-10-27 | 4 | Kiselak Tomas | MGEN | Director Stock Option (Right to Buy) | D | 0.52 | 24,000 | 24,000 | |||||
| 2020-10-29 | 2020-10-27 | 4 | Harwin Peter Evan | MGEN | Director Stock Option (Right to Buy) | D | 0.52 | 24,000 | 24,000 | |||||
| 2020-10-29 | 2020-10-27 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | MGEN | Series A Non-Voting Convertible Preferred Stock | I | 82,349 | 82,349 | ||||||
| 2020-10-29 | 2020-10-27 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | MGEN | Series A Non-Voting Convertible Preferred Stock | I | 16,505 | 16,505 | ||||||
| 2020-10-29 | 2020-10-27 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | MGEN | Common Stock | I | 438,502 | 438,502 | ||||||
| 2020-10-29 | 2020-10-27 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | MGEN | Common Stock | I | 87,891 | 87,891 | ||||||
| 2020-09-17 | 2020-09-13 | 4/A | Rauch Lee M. | MGEN | Stock Option (right to buy) | D | 0.91 | 900,000 | 900,000 | |||||
| 2020-09-15 | 2020-09-14 | 4 | Rauch Lee M. | MGEN | Stock Option (right to buy) | D | 0.91 | 900,000 | 900,000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Hatfield Jeffrey S. | MGEN | Stock Option (right to buy) | D | 0.63 | 24,000 | 24,000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | TURNER JOSEPH L | MGEN | Stock Option (right to buy) | D | 0.63 | 24,000 | 24,000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 0.63 | 24,000 | 24,000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | KOCH KEVIN | MGEN | Stock Option (right to buy) | D | 0.63 | 24,000 | 24,000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Morris Arlene | MGEN | Stock Option (right to buy) | D | 0.63 | 24,000 | 24,000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Bowden Christopher | MGEN | Stock Option (right to buy) | D | 0.63 | 24,000 | 24,000 | |||||
| 2020-03-17 | 2020-03-13 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 0.57 | -11,249 | 0 | |||||
| 2020-03-17 | 2020-03-13 | 4 | Leverone Jason A. | MGEN | Common Stock | D | 0.5700 | 11,249 | 6 | 48,829 | ||||
| 2020-02-14 | 2020-02-12 | 4 | Marshall William Stuart | MGEN | Stock Option (right to buy) | D | 0.80 | 464,000 | 464,000 | |||||
| 2020-02-14 | 2020-02-12 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 0.80 | 185,000 | 185,000 | |||||
| 2020-02-14 | 2020-02-12 | 4 | Escolar Diana | MGEN | Stock Option (right to buy) | D | 0.80 | 270,000 | 270,000 | |||||
| 2020-02-13 | 2019-08-21 | 5 | Marshall William Stuart | MGEN | Common Stock | D | 1.1390 | 1,250 | 1 | 270,646 | ||||
| 2020-02-13 | 2019-02-21 | 5 | Marshall William Stuart | MGEN | Common Stock | D | 2.4565 | 1,250 | 3 | 269,396 | ||||
| 2019-08-23 | 2019-08-23 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 0.57 | -3,093 | 0 | |||||
| 2019-08-23 | 2019-08-23 | 4 | Leverone Jason A. | MGEN | Common Stock | D | 0.5700 | 3,093 | 2 | 36,330 | ||||
| 2019-06-21 | 2019-06-19 | 4 | Bowden Christopher | MGEN | Stock Option (right to buy) | D | 2.36 | 12,000 | 12,000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Hatfield Jeffrey S. | MGEN | Stock Option (right to buy) | D | 2.36 | 12,000 | 12,000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 2.36 | 12,000 | 12,000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | KOCH KEVIN | MGEN | Stock Option (right to buy) | D | 2.36 | 12,000 | 12,000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Morris Arlene | MGEN | Stock Option (right to buy) | D | 2.36 | 12,000 | 12,000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | TURNER JOSEPH L | MGEN | Stock Option (right to buy) | D | 2.36 | 12,000 | 12,000 | |||||
| 2019-04-05 | 2019-04-03 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 2.99 | 10,106 | 10,106 | |||||
| 2019-02-08 | 2019-02-06 | 4 | Marshall William Stuart | MGEN | Stock Option (right to buy) | D | 2.96 | 232,000 | 232,000 | |||||
| 2019-02-08 | 2019-02-06 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 2.96 | 75,000 | 75,000 | |||||
| 2019-02-08 | 2019-02-06 | 4 | Levy Adam Scott | MGEN | Stock Option (right to buy) | D | 2.96 | 74,000 | 74,000 | |||||
| 2019-02-08 | 2019-02-06 | 4 | RUBIN PAUL D | MGEN | Stock Option (right to buy) | D | 2.96 | 87,000 | 87,000 | |||||
| 2018-10-12 | 2018-10-11 | 4 | Hughes Thomas E. | MGEN | Common Stock | D | 4.7697 | 10,000 | 48 | 12,827 | ||||
| 2018-08-09 | 2018-08-07 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 0.57 | -29,530 | 0 | |||||
| 2018-08-09 | 2018-08-07 | 4 | Leverone Jason A. | MGEN | Common Stock | D | 0.5700 | 29,530 | 17 | 30,737 | ||||
| 2018-06-28 | 2018-06-27 | 4 | Morris Arlene | MGEN | Stock Option (right to buy) | D | 6.46 | 12,000 | 12,000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | TURNER JOSEPH L | MGEN | Stock Option (right to buy) | D | 6.46 | 12,000 | 12,000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | Booth Bruce | MGEN | Stock Option (right to buy) | D | 6.46 | 12,000 | 12,000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | Bowden Christopher | MGEN | Stock Option (right to buy) | D | 6.46 | 12,000 | 12,000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | Hatfield Jeffrey S. | MGEN | Stock Option (right to buy) | D | 6.46 | 12,000 | 12,000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 6.46 | 12,000 | 12,000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | KOCH KEVIN | MGEN | Stock Option (right to buy) | D | 6.46 | 12,000 | 12,000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Marshall William Stuart | MGEN | Stock Option (right to buy) | D | 0.57 | -115,818 | 0 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Marshall William Stuart | MGEN | Common Stock | D | 0.5700 | 115,818 | 66 | 265,646 | ||||
| 2018-02-13 | 2018-02-13 | 4 | Booth Bruce | MGEN | Common Stock | I | 5.5000 | 545,454 | 3,000 | 1,351,090 | ||||
| 2018-02-13 | 2018-02-13 | 4 | Levy Adam Scott | MGEN | Common Stock | D | 5.5000 | 9,090 | 50 | 10,540 | ||||
| 2018-02-02 | 2018-01-31 | 4 | Marshall William Stuart | MGEN | Stock Option (right to buy) | D | 7.50 | 245,000 | 245,000 | |||||
| 2018-02-02 | 2018-01-31 | 4 | RUBIN PAUL D | MGEN | Stock Option (right to buy) | D | 7.50 | 85,000 | 85,000 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Levy Adam Scott | MGEN | Stock Option (right to buy) | D | 7.50 | 80,000 | 80,000 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 7.50 | 75,000 | 75,000 | |||||
| 2018-01-05 | 2018-01-03 | 4 | Booth Bruce | MGEN | Stock Option (right to buy) | D | 9.72 | 10,191 | 10,191 | |||||
| 2018-01-05 | 2018-01-03 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 9.72 | 3,426 | 3,426 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Hughes Thomas E. | MGEN | Common Stock | D | 8.0000 | -12,000 | -96 | 2,827 | ||||
| 2017-06-30 | 2017-06-28 | 4 | KOCH KEVIN | MGEN | Stock Option (right to buy) | D | 12.06 | 12,000 | 12,000 | |||||
| 2017-06-30 | 2017-06-28 | 4 | LEFKOFF KYLE | MGEN | Stock Option (right to buy) | D | 12.06 | 12,000 | 12,000 | |||||
| 2017-06-30 | 2017-06-28 | 4 | Booth Bruce | MGEN | Stock Option (right to buy) | D | 12.06 | 12,000 | 12,000 | |||||
| 2017-06-30 | 2017-06-28 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 12.06 | 12,000 | 12,000 | |||||
| 2017-06-30 | 2017-06-28 | 4 | Creecy John W | MGEN | Stock Option (right to buy) | D | 12.06 | 12,000 | 12,000 | |||||
| 2017-06-30 | 2017-06-28 | 4 | TURNER JOSEPH L | MGEN | Stock Option (right to buy) | D | 12.06 | 12,000 | 12,000 | |||||
| 2017-06-23 | 2017-06-22 | 4 | Levy Adam Scott | MGEN | Common Stock | D | 7.5500 | 200 | 2 | 200 | ||||
| 2017-03-28 | 2017-03-24 | 4 | Booth Bruce | MGEN | Stock Option (right to buy) | D | 11.80 | 6,844 | 6,844 | |||||
| 2017-03-28 | 2017-03-24 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 11.80 | 1,191 | 1,191 | |||||
| 2017-03-28 | 2017-03-24 | 4 | Hughes Thomas E. | MGEN | Common Stock | D | 778 | 14,840 | ||||||
| 2017-03-13 | 2017-03-10 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 14.3118 | -3,300 | -47 | 463,473 | ||||
| 2017-03-13 | 2017-03-09 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 14.3846 | -2,500 | -36 | 466,773 | ||||
| 2017-03-08 | 2017-03-08 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 14.7028 | -5,000 | -74 | 469,273 | ||||
| 2017-03-08 | 2017-03-06 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 16.2398 | -608 | -10 | 474,273 | ||||
| 2017-03-08 | 2017-03-06 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 15.7144 | -9,392 | -148 | 474,881 | ||||
| 2017-02-28 | 2017-02-28 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 13.5430 | -2,258 | -31 | 484,273 | ||||
| 2017-02-28 | 2017-02-27 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 13.7910 | -1,500 | -21 | 486,531 | ||||
| 2017-02-28 | 2017-02-24 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 14.0388 | -6,500 | -91 | 488,031 | ||||
| 2017-02-24 | 2017-02-23 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 13.6477 | -1,800 | -25 | 494,531 | ||||
| 2017-02-24 | 2017-02-22 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 14.3554 | -4,102 | -59 | 496,331 | ||||
| 2017-02-16 | 2017-02-16 | 4 | RUBIN PAUL D | MGEN | Stock Option (right to buy) | D | 11.01 | 87,500 | 87,500 | |||||
| 2017-02-16 | 2017-02-16 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 11.01 | 77,500 | 77,500 | |||||
| 2017-02-16 | 2017-02-16 | 4 | Marshall William Stuart | MGEN | Stock Option (right to buy) | D | 11.01 | 200,000 | 200,000 | |||||
| 2017-02-16 | 2017-02-16 | 4 | Levy Adam Scott | MGEN | Stock Option (right to buy) | D | 11.01 | 87,500 | 87,500 | |||||
| 2017-02-13 | 3 | Creecy John W | MGEN | Common Stock | I | 5,413,126 | ||||||||
| 2017-02-13 | 3 | Creecy John W | MGEN | Common Stock | I | 5,413,126 | ||||||||
| 2017-02-13 | 3 | Remeditex Ventures LLC | MGEN | Common Stock | D | 5,413,126 | ||||||||
| 2017-02-13 | 3 | Remeditex Ventures LLC | MGEN | Common Stock | D | 5,413,126 | ||||||||
| 2017-02-13 | 3 | Atlas Venture Fund VII L P | MGEN | Common Stock | D | 6,285,160 | ||||||||
| 2017-02-13 | 3 | Atlas Venture Fund VII L P | MGEN | Common Stock | D | 6,285,160 | ||||||||
| 2017-02-13 | 3 | LEFKOFF KYLE See Footnotes | MGEN | Common Stock | I | 2,608,303 | ||||||||
| 2017-02-13 | 3 | LEFKOFF KYLE See Footnotes | MGEN | Common Stock | I | 2,608,303 | ||||||||
| 2017-02-13 | 3 | LEFKOFF KYLE See Footnotes | MGEN | Common Stock | I | 3,715,307 | ||||||||
| 2017-02-13 | 3 | LEFKOFF KYLE See Footnotes | MGEN | Common Stock | I | 3,715,307 | ||||||||
| 2017-02-13 | 3 | Marshall William Stuart | MGEN | Common Stock | D | 297,156 | ||||||||
| 2017-02-13 | 3 | Marshall William Stuart | MGEN | Common Stock | D | 297,156 | ||||||||
| 2017-02-13 | 3 | Booth Bruce | MGEN | Common Stock | I | 7,090,796 | ||||||||
| 2017-02-13 | 3 | Booth Bruce | MGEN | Common Stock | I | 7,090,796 | ||||||||
| 2017-02-13 | 3 | Booth Bruce | MGEN | Common Stock | I | 4,753,852 | ||||||||
| 2017-02-13 | 3 | Booth Bruce | MGEN | Common Stock | I | 4,753,852 | ||||||||
| 2017-02-13 | 3 | Hughes Thomas E. | MGEN | Common Stock | D | 28,124 | ||||||||
| 2017-02-13 | 3 | Hughes Thomas E. | MGEN | Common Stock | D | 28,124 | ||||||||
| 2017-02-13 | 2017-02-13 | 4 | LEBOW BENNETT S | MGEN | Unsecured Demand Promissory Note | D | 5.39 | 0 | ||||||
| 2017-02-13 | 2017-02-13 | 4 | LEBOW BENNETT S | MGEN | Unsecured Demand Promissory Note | D | 5.39 | |||||||
| 2017-02-13 | 2017-02-13 | 4 | LEBOW BENNETT S | MGEN | Common Stock | D | 5.3900 | 279,067 | 1,504 | 280,600 | ||||
| 2017-02-08 | 2017-02-08 | 4 | Gonyer David A | SGNL | Stock Option (Right to Buy) | D | 7.65 | -1,200 | 0 | |||||
| 2017-02-08 | 2017-02-08 | 4 | Gonyer David A | SGNL | Common Stock | D | 7.6500 | 1,200 | 9 | 1,899 | ||||
| 2017-02-07 | 2017-02-03 | 4 | Smith Robin L | SGNL | Stock Option (Right to Buy) | D | 7.65 | -1,200 | 0 | |||||
| 2017-02-07 | 2017-02-03 | 4 | Smith Robin L | SGNL | Common Stock | D | 7.6500 | 1,200 | 9 | 1,900 | ||||
| 2017-02-07 | 2017-02-03 | 4 | LEBOW BENNETT S | SGNL | Stock Option (Right to Buy) | D | 7.65 | -1,200 | 0 | |||||
| 2017-02-07 | 2017-02-03 | 4 | LEBOW BENNETT S | SGNL | Common Stock | D | 7.6500 | 1,200 | 9 | 1,533 | ||||
| 2016-11-02 | 2016-10-31 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | 0.00 | -200,000 | 0 | |||||
| 2016-11-02 | 2016-10-31 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 0.3600 | -103,160 | -37 | 571,370 | ||||
| 2016-11-02 | 2016-10-31 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 200,000 | 674,530 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | -100,000 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | -46,000 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 0.3600 | -45,580 | -16 | 106,447 | ||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 100,000 | 152,027 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 0.3600 | -20,967 | -8 | 52,027 | ||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 46,000 | 72,994 | ||||||
| 2016-08-10 | 2016-08-08 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | -23,000 | 46,000 | ||||||
| 2016-08-10 | 2016-08-08 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 0.4850 | -10,484 | -5 | 26,994 | ||||
| 2016-08-10 | 2016-08-08 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 23,000 | 37,478 | ||||||
| 2016-06-30 | 2016-06-28 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | 0.00 | -124,251 | 0 | |||||
| 2016-06-30 | 2016-06-28 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 0.4600 | -64,835 | -30 | 474,530 | ||||
| 2016-06-30 | 2016-06-28 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 124,251 | 539,365 | ||||||
| 2016-06-20 | 2016-06-15 | 4 | Gonyer David A | SGNL | Stock Option (Right to Buy) | D | 0.51 | 18,000 | 18,000 | |||||
| 2016-06-20 | 2016-06-15 | 4 | Schuling Douglas A | SGNL | Stock Option (Right to Buy) | D | 0.51 | 18,000 | 18,000 | |||||
| 2016-06-20 | 2016-06-15 | 4 | Smith Robin L | SGNL | Stock Option (Right to Buy) | D | 0.51 | 18,000 | 18,000 | |||||
| 2016-06-20 | 2016-06-15 | 4 | LEBOW BENNETT S | SGNL | Stock Option (Right to Buy) | D | 0.51 | 18,000 | 18,000 | |||||
| 2016-05-19 | 2016-03-28 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | 0.00 | 200,000 | 200,000 | |||||
| 2016-05-19 | 2016-03-28 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | 0.00 | 100,000 | 100,000 | |||||
| 2016-02-12 | 2016-02-11 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | 0.00 | -124,252 | 124,251 | |||||
| 2016-02-12 | 2016-02-11 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 0.4600 | -54,268 | -25 | 415,114 | ||||
| 2016-02-12 | 2016-02-11 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 124,252 | 469,382 | ||||||
| 2015-11-23 | 2015-11-20 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 0.8000 | 7,000 | 6 | 345,130 | ||||
| 2015-11-23 | 2015-11-19 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 0.7800 | 7,000 | 5 | 338,130 | ||||
| 2015-08-14 | 2015-08-12 | 4 | SEYMOUR TAMARA A | SGNL | Employee Stock Option (Right to Buy) | D | 1.57 | 60,000 | 60,000 | |||||
| 2015-08-10 | 2015-08-06 | 4 | Gonyer David A | SGNL | Stock Option (Right to Buy) | D | 1.62 | 18,000 | 18,000 | |||||
| 2015-08-10 | 2015-08-06 | 4 | Gonyer David A | SGNL | Restricted Stock Units | D | -4,125 | 0 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Gonyer David A | SGNL | Common Stock | D | 5,000 | 10,500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Gonyer David A | SGNL | Common Stock | D | 4,125 | 5,500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Schuling Douglas A | SGNL | Stock Option (Right to Buy) | D | 1.62 | 18,000 | 18,000 | |||||
| 2015-08-10 | 2015-08-06 | 4 | Schuling Douglas A | SGNL | Restricted Stock Units | D | -4,125 | 0 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Schuling Douglas A | SGNL | Common Stock | D | 5,000 | 10,500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Schuling Douglas A | SGNL | Common Stock | D | 4,125 | 5,500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Smith Robin L | SGNL | Stock Option (Right to Buy) | D | 1.62 | 18,000 | 18,000 | |||||
| 2015-08-10 | 2015-08-06 | 4 | Smith Robin L | SGNL | Restricted Stock Units | D | -4,125 | 0 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Smith Robin L | SGNL | Common Stock | D | 5,000 | 10,500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Smith Robin L | SGNL | Common Stock | D | 4,125 | 5,500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | LEBOW BENNETT S | SGNL | Stock Option (Right to Buy) | D | 1.62 | 18,000 | 18,000 | |||||
| 2015-08-10 | 2015-08-06 | 4 | LEBOW BENNETT S | SGNL | Common Stock | D | 5,000 | 5,000 | ||||||
| 2015-08-05 | 2015-08-04 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | -23,000 | 69,000 | ||||||
| 2015-08-05 | 2015-08-04 | 4 | SEYMOUR TAMARA A | SGNL | Common Stock | D | 1.5600 | -8,522 | -13 | 14,478 | ||||
| 2015-08-05 | 2015-08-04 | 4 | SEYMOUR TAMARA A | SGNL | Common Stock | D | 23,000 | 23,000 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Smith Robin L | SGNL | Restricted Stock Units | D | -1,375 | 4,125 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Smith Robin L | SGNL | Common Stock | D | 1,375 | 1,375 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Schuling Douglas A | SGNL | Restricted Stock Units | D | -1,375 | 4,125 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Schuling Douglas A | SGNL | Common Stock | D | 1,375 | 1,375 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Gonyer David A | SGNL | Restricted Stock Units | D | -1,375 | 4,125 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Gonyer David A | SGNL | Common Stock | D | 1,375 | 1,375 | ||||||
| 2015-06-23 | 2015-06-19 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | -124,252 | 248,503 | ||||||
| 2015-06-23 | 2015-06-19 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 1.5100 | -46,036 | -70 | 331,130 | ||||
| 2015-06-23 | 2015-06-19 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 124,252 | 377,166 | ||||||
| 2015-04-10 | 2015-04-08 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | -372,756 | 372,755 | ||||||
| 2015-04-10 | 2015-04-08 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 2.0800 | -119,842 | -249 | 252,914 | ||||
| 2015-04-10 | 2015-04-08 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 372,756 | 372,756 | ||||||
| 2014-08-04 | 2014-08-04 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | 92,000 | 92,000 | ||||||
| 2014-07-21 | 2014-07-17 | 4 | Smith Robin L | SGNL | Restricted Stock Units | D | 5,500 | 5,500 | ||||||
| 2014-07-21 | 2014-07-17 | 4 | Smith Robin L | SGNL | Stock Option (right to buy) | D | 5.60 | 6,000 | 6,000 | |||||
| 2014-07-21 | 2014-07-17 | 4 | Gonyer David A | SGNL | Restricted Stock Units | D | 5,500 | 5,500 | ||||||
| 2014-07-21 | 2014-07-17 | 4 | Gonyer David A | SGNL | Stock Option (right to buy) | D | 5.60 | 6,000 | 6,000 | |||||
| 2014-07-21 | 2014-07-17 | 4 | Schuling Douglas A | SGNL | Restricted Stock Units | D | 5,500 | 5,500 | ||||||
| 2014-07-21 | 2014-07-17 | 4 | Schuling Douglas A | SGNL | Stock Option (right to buy) | D | 5.60 | 6,000 | 6,000 | |||||
| 2014-06-17 | 3 | LEBOW ALPHA, LLLP By LeBow Alpha, LLLP | SGNL | Common Stock, par value $0.01 per share | I | 4,465,258 | ||||||||
| 2014-06-17 | 3 | LEBOW ALPHA, LLLP By LeBow Alpha, LLLP | SGNL | Common Stock, par value $0.01 per share | I | 4,465,258 | ||||||||
| 2014-06-17 | 3 | LEBOW ALPHA, LLLP By LeBow Alpha, LLLP | SGNL | Common Stock, par value $0.01 per share | I | 4,465,258 |
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）
